Scientists who studied Vioxx deny ethics breach

Scientists who conducted a pivotal study of the blockbuster painkiller Vioxx yesterday insisted that they violated no ethical obligations by failing to include in a medical journal report all information about heart problems suffered by patients in the clinical trial. (Full article: 875 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly